久久午夜影院,国产大鸡巴九色,丰满人妻一区=区三区在线视频53,五月天婷婷激情四射在线观看

    <source id="7npa8"><tr id="7npa8"><dfn id="7npa8"></dfn></tr></source>
    1. 產(chǎn)品中心您現(xiàn)在的位置:首頁(yè) > 產(chǎn)品展示 > 抗體 > 內(nèi)參抗體 > InVivoMab anti-human PD-1 (CD279)

      InVivoMab anti-human PD-1 (CD279)

      更新時(shí)間:2022-01-27

      簡(jiǎn)要描述:

      The J116 monoclonal antibody reacts with human PD-1 (programmed death-1) also known as CD279. PD-1 is a 50-55 kDa cell surface receptor encoded by the Pdcd1 gene that belongs to the CD28 family of……

      型號(hào):廠商性質(zhì):代理商瀏覽量:990

      The J116 monoclonal antibody reacts with human PD-1 (programmed death-1) also known as CD279. PD-1 is a 50-55 kDa cell surface receptor encoded by the Pdcd1 gene that belongs to the CD28 family of the Ig superfamily. PD-1 is transiently expressed on CD4 and CD8 thymocytes as well as activated T and B lymphocytes and myeloid cells. PD-1 expression declines after successful elimination of antigen. Additionally, Pdcd1 mRNA is expressed in developing B lymphocytes during the pro-B-cell stage. PD-1's structure includes a ITIM (immunoreceptor tyrosine-based inhibitory motif) suggesting that PD-1 negatively regulates TCR signals. PD-1 signals via binding its two ligands, PD-L1 and PD-L2 both members of the B7 family. Upon ligand binding, PD-1 signaling inhibits T-cell activation, leading to reduced proliferation, cytokine production, and T cell death. Additionally, PD-1 is known to play key roles in peripheral tolerance and prevention of autoimmune disease in mice as PD-1 knockout animals show dilated cardiomyopathy, splenomegaly, and loss of peripheral tolerance. Induced PD-L1 expression is common in many tumors including squamous cell carcinoma, colon adenocarcinoma, and breast adenocarcinoma. PD-L1 overexpression results in increased resistance of tumor cells to CD8 T cell mediated lysis. In mouse models of melanoma, tumor growth can be transiently arrested via treatment with antibodies which block the interaction between PD-L1 and its receptor PD-1. For these reasons anti-PD-1 mediated immunotherapies are currently being explored as cancer treatments. Binding of the J116 antibody is reported to inhibit PD-1 signal transduction, however, it is not reported to block PD-L1 binding.


      產(chǎn)品名稱:InVivoMab anti-human PD-1 (CD279)

      反應(yīng)種屬:human

      宿主來(lái)源:mouse

      實(shí)驗(yàn)應(yīng)用:in vitro PD-1 neutralization, in vivo PD-1 blockade in humanized mice

      同種型:IgG1, κ

      克隆性:Monoclonal

      克隆號(hào):J116

      產(chǎn)品濃度:Lot specific,typically between 4-11 mg/ml

      保存溫度:Undiluted at 4°C in the dark

      運(yùn)輸溫度:Ship with adequate amount of blue ice to ensure the product remains at 4°C for the duration of transit

      預(yù)期分子量:150 kDa

      產(chǎn)品形式:液體

      有效期:One year from the date of receipt if stored as recommended

      產(chǎn)地:美國(guó)



      如需購(gòu)買或咨詢Bioxcell公司的產(chǎn)品,請(qǐng)聯(lián)系Bioxcell*代理商欣博盛生物


      留言框

      • 產(chǎn)品:

      • 您的單位:

      • 您的姓名:

      • 聯(lián)系電話:

      • 常用郵箱:

      • 省份:

      • 詳細(xì)地址:

      • 補(bǔ)充說(shuō)明:

      • 驗(yàn)證碼:

        請(qǐng)輸入計(jì)算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7